Glossary

Specificity

Specificity is the proportion of true negatives correctly identified by a diagnostic test, measuring its ability to exclude a disease when it is absent.

Get in touch Learn more

Moody home-office setup in a converted highrise loft, analyst working late with multiple screens showing knowledge graph visualizations, city lights through large windows behind.

TRUE NEGATIVE RATE

What is Specificity?

Specificity is a statistical measure of a binary classification test's ability to correctly identify true negatives, quantifying its capacity to rule out a disease in healthy patients.

Specificity is the proportion of patients without a target condition who are correctly identified by a diagnostic test as negative. Mathematically, it is calculated as True Negatives / (True Negatives + False Positives). A highly specific test minimizes false positives, ensuring that healthy individuals are rarely mislabeled as having a disease, which is critical for avoiding unnecessary invasive follow-up procedures and psychological distress.

In Software as a Medical Device (SaMD) regulatory submissions, specificity is a primary endpoint in analytical validation and clinical evaluation studies. It is intrinsically linked to the ROC Curve, where it is plotted as (1 - False Positive Rate). A test with 100% specificity perfectly excludes disease, but in practice, a trade-off with sensitivity is managed by adjusting the classifier's operating threshold to balance clinical risk.

DIAGNOSTIC ACCURACY METRICS

Specificity vs. Sensitivity

A comparative analysis of the two core statistical measures of binary diagnostic test performance, highlighting their distinct clinical roles and mathematical independence.

Feature	Specificity	Sensitivity	Clinical Impact
Core Definition	Proportion of true negatives correctly identified	Proportion of true positives correctly identified	Both are required for diagnostic accuracy
Primary Clinical Question	How well does the test rule OUT disease?	How well does the test rule IN disease?	Determines test utility in screening vs. confirmation
Mathematical Formula	TN / (TN + FP)	TP / (TP + FN)	Independent of disease prevalence
Ideal Value	100% (no false positives)	100% (no false negatives)	Trade-off exists; perfection is rare
Consequence of Failure	False positives lead to unnecessary invasive procedures	False negatives lead to missed diagnoses and disease progression	Risk tolerance varies by disease severity
High-Value Clinical Scenario	Cancer screening where biopsy carries risk	Emergency rule-out for life-threatening conditions	SNOUT and SPIN mnemonics apply
Regulatory Threshold (Typical)	80% for screening SaMD	90% for diagnostic SaMD	FDA evaluates both in substantial equivalence
Relationship to ROC Curve	Defines the x-axis complement (1 - Specificity)	Defines the y-axis (True Positive Rate)	AUC summarizes the trade-off across thresholds

Enabling Efficiency, Speed & Accuracy

Intelligent Analysis, Decision & Execution

We build AI systems for teams that need search across company data, workflow automation across tools, or AI features inside products and internal software.

Talk to Us

Search across company data

Give teams answers from docs, tickets, runbooks, and product data with sources and permissions.

Useful when people spend too long searching or get different answers from different systems.

Enterprise searchRAGPermissions

Automate internal workflows

Use AI to route work, draft outputs, trigger actions, and keep approvals and logs in place.

Useful when repetitive work moves across multiple tools and teams.

AI agentsWorkflow automationGovernance

Add AI to products and internal tools

Build assistants, guided actions, or decision support into the software your team or customers already use.

Useful when AI needs to be part of the product, not a separate tool.

AI integrationDecision supportModel routing

DIAGNOSTIC ACCURACY

Frequently Asked Questions

Clear, concise answers to the most common questions about specificity and its critical role in evaluating the performance of diagnostic AI and medical devices.

Specificity is the proportion of true negatives correctly identified by a diagnostic test, measuring its ability to accurately exclude a disease when it is absent. It is calculated as True Negatives / (True Negatives + False Positives). A test with high specificity will rarely misclassify a healthy patient as having the disease, resulting in a low false positive rate. In the context of Software as a Medical Device (SaMD), demonstrating high specificity is crucial during analytical validation and clinical evaluation to prove the algorithm does not generate spurious findings that could lead to unnecessary, costly, or invasive follow-up procedures.

DIAGNOSTIC PERFORMANCE METRICS

Related Terms

Understanding specificity requires a holistic view of the diagnostic performance ecosystem. These interconnected metrics and regulatory concepts define how a test's ability to correctly exclude disease is evaluated, validated, and cleared for clinical use.

Sensitivity

The counterbalance to specificity, sensitivity measures the proportion of true positives correctly identified by a diagnostic test. It answers: If the disease is present, how likely is the test to catch it?

Formula: True Positives / (True Positives + False Negatives)
A highly sensitive test minimizes false negatives, making it ideal for screening where missing a diagnosis is dangerous.
Trade-off: Sensitivity and specificity are often inversely related; adjusting the decision threshold to increase one typically decreases the other.

TP / (TP + FN)

Formula

ROC Curve

The Receiver Operating Characteristic (ROC) curve visualizes the trade-off between sensitivity and specificity across all possible classification thresholds.

Plots True Positive Rate (Sensitivity) on the y-axis against False Positive Rate (1 - Specificity) on the x-axis.
The Area Under the Curve (AUC) quantifies overall diagnostic accuracy: an AUC of 1.0 represents perfect discrimination, while 0.5 indicates a useless test.
Engineers use the ROC curve to select the optimal operating point that balances false alarms against missed detections for a specific clinical context.

Diagnostic Accuracy

Diagnostic accuracy is the overall probability that a test correctly classifies a patient, combining both sensitivity and specificity into a single metric.

Formula: (True Positives + True Negatives) / Total Population
While useful for a high-level summary, accuracy can be misleading in datasets with high class imbalance. A test that simply guesses 'negative' in a population with 99% healthy patients will have 99% accuracy but 0% sensitivity.
Always evaluate accuracy alongside sensitivity and specificity to avoid being deceived by prevalence effects.

Clinical Validation Study Design

To make a regulatory claim about specificity, manufacturers must conduct a clinical validation study that rigorously proves the metric in the intended use population.

Studies must be statistically powered to demonstrate the lower bound of the 95% confidence interval for specificity exceeds a clinically acceptable threshold.
Requires an independent ground truth reference standard (e.g., biopsy, surgical confirmation, or expert panel consensus) against which the AI's negative calls are compared.
The study protocol, including pre-specified endpoints for specificity, is a critical component of the Design History File (DHF) for FDA submission.

Predicate Device

In a 510(k) Premarket Notification, specificity is a key performance characteristic used to demonstrate Substantial Equivalence (SE) to a legally marketed predicate device.

The sponsor must show that their SaMD's specificity is at least as high as the predicate's in a comparable clinical setting.
If a novel device has no predicate and presents a low-to-moderate risk, a De Novo Classification Request is used, where the FDA establishes special controls that define acceptable specificity benchmarks for that new device type.

Analytical Validation

Before clinical specificity is proven, analytical validation establishes the test's technical precision in a controlled lab setting, free from patient variables.

Measures analytical specificity, which assesses interference from cross-reactive substances or conditions that could cause a false positive result.
For imaging AI, this involves testing the model's robustness to variations in scanner manufacturer, acquisition protocol, and image reconstruction parameters.
A stable, high analytical specificity is a prerequisite for proceeding to costly clinical validation trials.

About the author

Prasad Kumkar

CEO & MD, Inference Systems

Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.

His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.

Limited slotsGet a Free AI Consultation

How We Work

Custom AI workflows for your Business

One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.

Talk to Us